Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list Medical Dialogues Bureau29 Nov 2019 3:45 AM GMTSeventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab, br...
Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh Medical Dialogues Bureau8 Nov 2019 4:00 AM GMT'We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China war...
Centre ask States not to partner with Philip Morris-led anti-smoking group Medical Dialogues Bureau2 July 2019 3:45 AM GMTIndia's federal health ministry has sent a letter, dated June 24, to chief secretaries of all states, saying they should not partner with FSFW and also...
GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma Medical Dialogues Bureau8 Jun 2019 4:30 AM GMTThe price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough liquids,...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 5:30 AM GMTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from C...
China war on healthcare costs lure Indian drugmaker Sun Pharma: Report Medical Dialogues Bureau6 May 2019 3:45 AM GMTChina has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers like...
Tencent-backed China online healthcare venture raises $250 million Garima25 April 2019 5:37 AM GMTBEIJING: China's Tencent Trusted Doctor, a venture backed by tech giant Tencent Holdings, said it has raised $250 million in a fundraising round, as...
Pfizer, GSK consumer healthcare venture to focus on China, US market Farhat Nasim7 April 2019 3:44 AM GMTLONDON: The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the...
China vaccine scandal ripples through domestic market, threatens global push Ruby Khatun Khatun24 July 2018 4:15 AM GMTSHANGHAI: A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples...
Over 75 percent of Indian drug import comes from China says pharma body IPCA Ruby Khatun Khatun21 Dec 2017 4:00 AM GMTNew Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
China accounts for 66 percent of India's bulk drug imports in FY'17 Ruby Khatun Khatun20 Dec 2017 4:45 AM GMTNew Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
AstraZeneca steps up China push with new drug joint venture Ruby Khatun Khatun28 Nov 2017 8:20 AM GMTLONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
